Drug recall · January 7, 2026
Ondansetron Orally Disintegrating Tablets recall
Why: Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and tablets falling out. Preferred Pharmaceuticals purchased the finished product and repackaged the product for sale.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ondansetron Orally Disintegrating Tablets, USP, 4mg, 30 Tablets (3 blistercards each containing 10 tablets), Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-157-13
- Lots / codes
Lot #: 19251311, Exp Date April 2027
- Quantity
- 96,948 packs
- Company
- Glenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ
- Distribution
- Nationwide within the United States
- Initiated
- December 30, 2025 · Voluntary: Firm initiated
- Classified
- December 31, 2025
- Reported
- January 7, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ondansetron
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.